GenMark Diagnostics to Present at 16th Annual Needham Healthcare Conference
March 28 2017 - 6:53PM
Business Wire
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, will
present at the 16th Annual Needham Healthcare Conference to be held
at the Westin Grand Central in New York on Wednesday, April 5,
2017. The presentation will be delivered by Hany Massarany,
President and Chief Executive Officer, and is scheduled to begin at
10:40 A.M. Eastern Time. The presentation will be made available at
http://ir.genmarkdx.com/.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of
automated, multiplex molecular diagnostic testing systems that
detect and measure DNA and RNA targets to diagnose disease and
optimize patient treatment. Utilizing GenMark’s proprietary
eSensor® detection technology, GenMark’s eSensor XT-8® system is
designed to support a broad range of molecular diagnostic tests
with a compact, easy-to-use workstation and self-contained,
disposable test cartridges. The eSensor detection technology is
also incorporated into GenMark’s new sample-to-answer system
ePlex®. For more information, visit www.genmarkdx.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170328006549/en/
GenMark Diagnostics, Inc.Hany Massarany, 760-448-4325President,
Chief Executive Officer
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Mar 2024 to Apr 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Apr 2023 to Apr 2024
